The CLINITEST Rapid COVID-19 Antigen Self-Test recently received FDA Emergency Use Authorization. The test is available and already supporting COVID-19...
Navenio strengthens senior team with the appointment of a new CEO to build out its global offering, after securing first...
STOCKHOLM, SE / ACCESSWIRE / February 3, 2022 / Vimian Group (STO:VIMIAN)Vimian Group has today signed an agreement to acquire...
ANVISA (Brazilian Health Authority) approved Biophytis' Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in...
Grand Opening of International Cancer and Chronic Pain InstituteLONDON, UK / ACCESSWIRE / February 3, 2022 / Apollon Formularies plc...
Directorate Changes - Garry Cook and Graham Mullis join BoardLONDON, UK / ACCESSWIRE / February 3, 2022 / Love Hemp...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
– Revenue of $1.471 Billion, GAAP Diluted EPS of $1.95, and Non-GAAP Diluted EPS of $2.17 All Significantly Exceed Expectations...
TORONTO, ON / ACCESSWIRE / February 2, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") is pleased to announce...
FT MYERS, FL / ACCESSWIRE / February 2, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
Calgary, Alberta--(Newsfile Corp. - February 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 2, 2022) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:...
More than 96% of athenaOne® clinicians received positive payment adjustments WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc., a leading provider of network-enabled software...
Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINKJUPITER, FL / ACCESSWIRE / February...
GOTHENBURG, SE / ACCESSWIRE / February 2, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)XVIVO Perfusion AB has gained regulatory...
GOLDEN, CO / ACCESSWIRE / February 2, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), ("Panacea" or the "Company"), a Colorado,...
Additional Talent Enables the Company to Pursue COVID-19 Testing Accreditation within the Province of British ColumbiaVANCOUVER, BC / ACCESSWIRE /...
Expansion reflects Bicycle Health's mission to make evidence-based OUD treatment accessible nationwide Bicycle Health is now available in 24 states...
By investing in OmnySense, Texas Medical ramps up its mission to enhance healthcare through solutions minimizing the risk of deterioration...
Ottawa, Ontario--(Newsfile Corp. - February 2, 2022) - According to a national poll conducted by Abacus Data for the Canadian...